Pietro Geri

Trieste, 34149, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Effectiveness of Desensitization Therapy for Grasses and Dust Mites on Asthma Exacerbations and Respiratory Function During the Allergy Season: A Pilot Study.

Effectiveness of Desensitization Therapy for Grasses and Dust Mites on Asthma Exacerbations and Respiratory Function During the Allergy Season: A Pilot Study.

Journal: Journal of clinical medicine

Published: December 25, 2025

Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice.

Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice.

Journal: Journal of clinical medicine

Published: July 27, 2025

Comorbidities' Effect on IPF: Pathogenesis and Management.

Comorbidities' Effect on IPF: Pathogenesis and Management.

Journal: Biomedicines

Published: April 14, 2025

Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud's Phenomenon.

Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud's Phenomenon.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 09, 2024

Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.

Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 04, 2024

Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.

Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 24, 2024

Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows.

Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 11, 2024

Biomarkers in Systemic Sclerosis: An Overview.

Biomarkers in Systemic Sclerosis: An Overview.

Journal: Current issues in molecular biology

Published: September 02, 2023

Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story?

Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story?

Journal: Heliyon

Published: September 18, 2022

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 22, 2022

Chronic Thromboembolic Pulmonary Hypertension: An Observational Study.

Chronic Thromboembolic Pulmonary Hypertension: An Observational Study.

Journal: Medicina (Kaunas, Lithuania)

Published: June 19, 2022

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?

Journal: Journal of clinical medicine

Published: May 28, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026